- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x ZN: ZINC ION(Non-covalent)
ZN.2: 4 residues within 4Å:- Chain A: H.178, C.182, C.184, C.187
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.178, A:C.182, A:C.184, A:C.187
ZN.8: 4 residues within 4Å:- Chain B: H.178, C.182, C.184, C.187
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:H.178, B:C.182, B:C.184, B:C.187
ZN.12: 4 residues within 4Å:- Chain C: H.178, C.182, C.184, C.187
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:H.178, C:C.182, C:C.184, C:C.187
ZN.18: 4 residues within 4Å:- Chain D: H.178, C.182, C.184, C.187
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:H.178, D:C.182, D:C.184, D:C.187
- 4 x 98R: [(2S)-2-[(E)-octadec-10-enoyl]oxy-3-oxidanyl-propyl] octadec-10-enoate(Non-covalent)
98R.4: 10 residues within 4Å:- Chain A: F.606, K.607, F.610, W.611
- Chain B: N.633, Y.636, I.641, V.644, T.645
- Ligands: POV.6
11 PLIP interactions:6 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:F.606, A:F.606, A:F.610, A:F.610, A:F.610, B:I.641, B:V.644, B:V.644, B:T.645
- Hydrogen bonds: A:K.607, B:N.633
98R.10: 10 residues within 4Å:- Chain B: F.606, K.607, F.610, W.611
- Chain D: N.633, Y.636, I.641, V.644, T.645
- Ligands: POV.16
11 PLIP interactions:5 interactions with chain D, 6 interactions with chain B- Hydrophobic interactions: D:I.641, D:V.644, D:V.644, D:T.645, B:F.606, B:F.606, B:F.610, B:F.610, B:F.610
- Hydrogen bonds: D:N.633, B:K.607
98R.14: 10 residues within 4Å:- Chain A: N.633, Y.636, I.641, V.644, T.645
- Chain C: F.606, K.607, F.610, W.611
- Ligands: POV.5
11 PLIP interactions:5 interactions with chain A, 6 interactions with chain C- Hydrophobic interactions: A:I.641, A:V.644, A:V.644, A:T.645, C:F.606, C:F.606, C:F.610, C:F.610, C:F.610
- Hydrogen bonds: A:N.633, C:K.607
98R.20: 10 residues within 4Å:- Chain C: N.633, Y.636, I.641, V.644, T.645
- Chain D: F.606, K.607, F.610, W.611
- Ligands: POV.15
11 PLIP interactions:6 interactions with chain D, 5 interactions with chain C- Hydrophobic interactions: D:F.606, D:F.606, D:F.610, D:F.610, D:F.610, C:I.641, C:V.644, C:V.644, C:T.645
- Hydrogen bonds: D:K.607, C:N.633
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.5: 13 residues within 4Å:- Chain A: D.627, K.629, F.630, N.633, I.634
- Chain C: S.466, A.470, P.519, I.525, L.529, I.532
- Ligands: Y01.13, 98R.14
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain C- Hydrophobic interactions: A:K.629, A:N.633, A:I.634, C:A.470, C:I.525, C:I.525, C:L.529
POV.6: 13 residues within 4Å:- Chain A: S.466, A.470, P.519, I.525, L.529, I.532
- Chain B: D.627, K.629, F.630, N.633, I.634
- Ligands: Y01.3, 98R.4
7 PLIP interactions:3 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:K.629, B:N.633, B:I.634, A:A.470, A:I.525, A:I.525, A:L.529
POV.15: 13 residues within 4Å:- Chain C: D.627, K.629, F.630, N.633, I.634
- Chain D: S.466, A.470, P.519, I.525, L.529, I.532
- Ligands: Y01.19, 98R.20
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain D- Hydrophobic interactions: C:K.629, C:N.633, C:I.634, D:A.470, D:I.525, D:I.525, D:L.529
POV.16: 13 residues within 4Å:- Chain B: S.466, A.470, P.519, I.525, L.529, I.532
- Chain D: D.627, K.629, F.630, N.633, I.634
- Ligands: Y01.9, 98R.10
7 PLIP interactions:4 interactions with chain B, 3 interactions with chain D- Hydrophobic interactions: B:A.470, B:I.525, B:I.525, B:L.529, D:K.629, D:N.633, D:I.634
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Guo, W. et al., Structural mechanism of human TRPC3 and TRPC6 channel regulation by their intracellular calcium-binding sites. Neuron (2022)
- Release Date
- 2022-02-02
- Peptides
- Short transient receptor potential channel 3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x 98R: [(2S)-2-[(E)-octadec-10-enoyl]oxy-3-oxidanyl-propyl] octadec-10-enoate(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Guo, W. et al., Structural mechanism of human TRPC3 and TRPC6 channel regulation by their intracellular calcium-binding sites. Neuron (2022)
- Release Date
- 2022-02-02
- Peptides
- Short transient receptor potential channel 3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.